Asymptomatic Metastatic Carcinoid Tumor Discovered by Routine Screening Mammography

2017 ◽  
Vol 83 (2) ◽  
pp. 60-62
Author(s):  
Julia L. Brothers ◽  
Mark A. Mikhitarian ◽  
Lee S. Fleischer
Keyword(s):  
Carcinoid Tumor ◽  
Screening Mammography ◽  
Routine Screening ◽  
Metastatic Carcinoid

Abstract #737: Multiple Liver-Directed Therapy Including Theraspheres for Recurrent Metastatic Carcinoid Tumor

2015 ◽  
Vol 21 ◽  
pp. 143-144
Author(s):  
Mohammed Ahmed ◽  
Hamad Alsuhaibani ◽  
Tarek Amin ◽  
Hindi Alhindi ◽  
Mahmoud Tuli
Keyword(s):  
Carcinoid Tumor ◽  
Metastatic Carcinoid

A hyperdense intracranial metastatic carcinoid tumor

1990 ◽  
Vol 88 (3) ◽  
pp. 314-316 ◽  
Author(s):  
Donald L. Gordon ◽  
John F. Shea ◽  
Ketty Badrinath ◽  
Michael Fine ◽  
Meena Gujrati
Keyword(s):  
Carcinoid Tumor ◽  
Metastatic Carcinoid

Metastatic carcinoid tumor in the liver

1993 ◽  
Vol 21 (9) ◽  
pp. 639-641 ◽  
Author(s):  
Vikram Singh Dogra ◽  
Jesse Poblete
Keyword(s):  
Carcinoid Tumor ◽  
Metastatic Carcinoid

The value of routine screening mammography in women aged 35–39 years in a symptomatic breast unit

2017 ◽  
Vol 72 (6) ◽  
pp. 517.e7-517.e12 ◽  
Author(s):  
A. Buckley ◽  
N. Healy ◽  
A. Quinn ◽  
S.A. O'Keeffe
Keyword(s):  
Screening Mammography ◽  
Routine Screening ◽  
Breast Unit ◽  
Symptomatic Breast

scholarly journals A case of metastatic carcinoid tumor of the pancreas resected by laparoscopic distal pancreatectomy.

HPB ◽  
2019 ◽  
Vol 21 ◽  
pp. S677
Author(s):  
S. Takamatsu ◽  
T. Furuyama ◽  
S. Kato ◽  
H. Nagano ◽  
S. Ohtsukasa ◽  
...  
Keyword(s):  
Distal Pancreatectomy ◽  
Carcinoid Tumor ◽  
Laparoscopic Distal Pancreatectomy ◽  
Metastatic Carcinoid

METASTATIC CARCINOID TUMOR CAUSING BILIARY OBSTRUCTION

2003 ◽  
Vol 98 ◽  
pp. S194-S195
Author(s):  
Brian D. Zipser ◽  
Samir A. Shah ◽  
Edward R. Feller
Keyword(s):  
Carcinoid Tumor ◽  
Biliary Obstruction ◽  
Metastatic Carcinoid

Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor.

1984 ◽  
Vol 2 (11) ◽  
pp. 1255-1259 ◽  
Author(s):  
P F Engstrom ◽  
P T Lavin ◽  
C G Moertel ◽  
E Folsch ◽  
H O Douglass
Keyword(s):  
Heart Disease ◽  
Carcinoid Tumor ◽  
Response Rate ◽  
Renal Toxicity ◽  
Response Duration ◽  
Hematologic Toxicity ◽  
Metastatic Carcinoid ◽  
Median Response ◽  
Prior Chemotherapy ◽  
Phase Ii And Iii

EST 5275 is a phase II and III study of fluorouracil plus streptozocin (5-FU plus STZ) or doxorubicin in patients with measurable progressive carcinoid tumor. Among one hundred seventy-two cases with no prior chemotherapy and no heart disease, the response rate was 22% for 5-FU plus STZ and 21% for doxorubicin, while the median response duration and median survival were 31 weeks and 64 weeks for the combination and 26 weeks and 48 weeks for doxorubicin. Thirty-three patients who failed 5-FU plus STZ crossed over to doxorubicin and achieved an 18% response. Of the thirty-five patients who failed on doxorubicin, 29% responded to 5-FU plus STZ. Hematologic toxicity was similar for both treatments; however, the 5-FU plus STZ patients experienced more vomiting but acceptable renal toxicity. Both chemotherapy regimens have antitumor activity in carcinoid tumors.

Likelihood of additional work-up among women undergoing routine screening mammography: the impact of age, breast density, and hormone therapy use

2004 ◽  
Vol 39 (1) ◽  
pp. 48-55 ◽  
Author(s):  
Patricia A Carney ◽  
Claudia J Kasales ◽  
Anna N.A Tosteson ◽  
Julia E Weiss ◽  
Martha E Goodrich ◽  
...  
Keyword(s):  
Hormone Therapy ◽  
Breast Density ◽  
Screening Mammography ◽  
Routine Screening ◽  
Additional Work ◽  
The Impact ◽  
Work Up
Sign in / Sign up

Export Citation Format

Share Document